 It serves as an antifibrinolytic by reversibly binding four to five lysine receptor sites on plasminogen.This reduces conversion of plasminogen to plasmin, preventing fibrin degradation and preserving the framework of fibrin's matrix structure.Tranexamic acid has roughly eight times the antifibrinolytic activity of an older analogue, ε-aminocaproic acid.